Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma-Reference-Cited by-同舟云学术

Prognostic value of bax, bcl-2, and p53 staining in primary osteosarcoma

Published:2008 Issue:3 Volume:97 Page:259-266
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Kaseta Maria-Kyriaki A.,Khaldi Lubna,Gomatos Ilias P.,Tzagarakis George P.,Alevizos Leonidas,Leandros Emmanuel,Papagelopoulos Panayiotis J.,Soucacos Panayiotis N.

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference33 articles.

1. Comparison ofp53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma

2. Clinical relevance of p53 and bcl-2 protein over-expression in laryngeal squamous-cell carcinoma

3. Evaluation of multiple bio-pathological factors in colorectal adenocarcinomas: Independent prognostic role of p53 and bcl-2

4. Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate Cancer

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma;Genes;2023-03-30

2. Regulated cell death and drug resistance in malignant bone tumors;Bone Cancer;2022

3. Up-regulation of LINC00619 promotes apoptosis and inhibits proliferation, migration and invasion while promoting apoptosis of osteosarcoma cells through inactivation of the HGF-mediated PI3K-Akt signalling pathway;Epigenetics;2021-04-02

4. Mechanisms of Resistance to Conventional Therapies for Osteosarcoma;Cancers;2021-02-08

5. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways;The Journal of Pathology: Clinical Research;2021-01-08